Takeda partners with Zydus to develop chikungunya vaccine
September 20, 2016Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya
Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …
GSK appoints Emma Walmsley as CEO
September 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment
GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Duchenne drug gets FDA approval in “unprecedented” ruling
September 20, 2016Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, FDA, sarepta
The FDA has gone against the advice of its own staff to approve the first treatment of Duchenne muscular dystrophy …
PCI Pharma Services to Share Expertise at Free Serialization Forum
September 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services
Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …
Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services
September 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield
Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …
NICE rejects expanded treatment indication for Roche’s Esbriet
September 19, 2016Sales and Marketing Esbriet, NICE, Roche, rejection
NICE has published a final appraisal rejecting the expanded use of Roche’s Esbriet (pirfenidone) for the treatment of early idiopathic …
EU recommendation for Lilly’s soft tissue cancer drug
September 19, 2016Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma
The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …
J&J in $4.33bn eye surgery unit acquisition
September 19, 2016Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition
Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …
“First of its kind” manufacturing campus to bring 500 jobs to Ireland
September 19, 2016Manufacturing and Production, Sales and Marketing GE Healthcare, Ireland, manufacturing
Biopharma firm GE Healthcare has made a major investment to create a ‘BioPark’ in Ringaskiddy, Ireland, set to generate 500 …
Sanofi accuses MSD of US patent infringement
September 19, 2016Sales and Marketing MSD, Sanofi, lawsuit
Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …
Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia
September 16, 2016Medical Communications University of Glasgow, chronic myeloid leukaemia
Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
Teva and Intel team up to tackle Huntington’s with wearable tech
September 16, 2016Medical Communications Huntington's, Intel, Teva, wearable tech
Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …
Dechra signs £31 million acquisition
September 16, 2016Medical Communications Apex Laboratories, Dechra, acquisition
Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …
Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk
September 16, 2016Medical Communications Novo Nordisk, diabetes, semaglutide
Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …
Cirrus – a new name for specialist artwork services
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …
New immunology and inflammation research global head and North American CSO for Sanofi
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment
Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …
Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment
Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …
Allergan snaps up Vitae Pharma for $639 million
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition
Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
UK Biopharma and life after Brexit
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
